Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

patient expectations

- PMLiVE

J&J says COVID-19 vaccine could be ready in early 2021

Also receives US federal backing to increase manufacturing for the shot

- PMLiVE

Merck, Bayer flesh out vericiguat heart failure data at ACC

Drug reduced rate of cardiovascular deaths and hospitalisations

- PMLiVE

Start small but think big

Exploring the potential of agility in unlocking creativity

The Pivot

In times of uncertainty it is critical for businesses to take action to protect their brand image and longevity.

Page & Page Health

- PMLiVE

FDA grants emergency authorisation to chloroquine for COVID-19

Novartis and Bayer donate anti-malaria drugs to US stockpile

- PMLiVE

Behaviour change – is there something missing?

Successful and impactful behaviour change requires commitment and time

Bedrock Healthcare Communications

Sanofi reception

Sanofi doses first patient in global Kevzara COVID-19 trial

Sanofi is leading trials outside the US while Regeneron is leading US trials

- PMLiVE

Lundbeck drops Parkinson’s drug acquired in €905m deal

Disappointment after drug failed in a mid-stage clinical trial

- PMLiVE

The global antibiotic crisis: a 2020 perspective

A report from the CDC says the ‘approaching’ post-antibiotic era is already here

- PMLiVE

UK contributes £210m towards COVID-19 vaccine efforts

Prime Minister Boris Johnson also tests positive for coronavirus

- PMLiVE

Bluebird bio pushes back commercial launch of Zynteglo due to COVID-19

First patient is likely to be treated later in the year due to pandemic

- PMLiVE

In virtual meeting, CHMP backs Sanofi’s myeloma drug Sarclisa

Monthly meeting held remotely for the first time due to COVID-19 pandemic

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links